RecruitingNCT04688593

Clinical and Functional Outcome of the MobileLink Acetabular Cup System in the Short-, Mid-, and Longterm Follow-up


Sponsor

Waldemar Link GmbH & Co. KG

Enrollment

520 participants

Start Date

May 4, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The implantation of artificial hip joints is one of the most frequently performed surgeries. Normally, patients are very satisfied with the results. The MobileLink hip prosthesis system is a CE marked medical device. This means the the safety and performance of the prosthesis ist approved. Aim of the study is to collect clinical data about the outcome of the MobileLink hip prosthesis system under routine condition and to determine the satisfaction of the patients.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called MobileLink for people with osteoarthritis, hip, prosthesis failure, and other related conditions. The study is currently recruiting participants at 2 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMobileLink

Patients who receive a MobileLink hip prosthesis system will be followed-up for 10 years.


Locations(2)

Lubinus Stiftung

Kiel, Germany

NHS FIFE Victoria Hospital

Kirkcaldy, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04688593


Related Trials